Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

ABIVAX Société Anonyme (ENXTPA:ABVX) just released new late-breaking Phase 3 trial data for obefazimod, showing positive clinical responses and remission rates in patients with moderate to severely ...

Countries that did not run bilateral trade surpluses with the U.S. are now subject to a universal 10 percent rate. In ...

Bihar's assembly elections are set for November 6 and 11. Political parties are in a race to finalize alliances and declare ...

ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a favorable safety and ...

As HSBC readies a multi?billion?pound risk transfer and a $14?B Hang?Seng buyout, the bank is quietly reshaping its capital ...

The PFRDA Grade A Phase 2 Exam 2025 featured Paper 1, the English Descriptive Test, as manageable, while Paper 2, the ...

The veteran Middle East negotiators Hussein Agha and Robert Malley assess the promises and pitfalls of Trump’s peace deal.

The government shutdown is delaying another major economic report, leaving policymakers at the Federal Reserve with a ...

A team from the Faculty of Physics and the Center for Quantum Optical Technologies at the University of Warsaw has developed a new type of all-optical radio receiver based on the fundamental ...

Analysts are closely monitoring the top cryptos for short-term and mid-term gains. Ethereum (ETH) and Solana (SOL) do ...

Tutor Perini faces margin pressure and valuation concerns despite strong backlog and revenue visibility. Learn why TPC stock ...